Moreover, the transcriptomics analysis revealed other potential components in small portions, including lipases, phospholipases, superoxide dismutases (SOD), aminopeptidases, metalloproteases, insulin-like growth factor-binding proteins (IGFBP), cysteine proteases, hyaluronidases, acetylcholinesterases (ACE), nucleotidases, anti-Alzheimer’s diseases peptides, SPRY domain-containing proteins, sphingomyelinases, catalases, and L-amino-acid oxidases (LAAO) in the present study. The gene discussed is IL4I1; the disease is early-onset autosomal dominant Alzheimer disease.